Chemoinformaics analysis of (+)-epi-beta-santalol
Molecular Weight | 262.393 | nRot | 5 |
Heavy Atom Molecular Weight | 236.185 | nRig | 11 |
Exact Molecular Weight | 262.193 | nRing | 2 |
Solubility: LogS | -5.06 | nHRing | 0 |
Solubility: LogP | 4.247 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 47.3306 |
nHD | 0 | BPOL | 28.6874 |
QED | 0.546 |
Synth | 4.744 |
Natural Product Likeliness | 3.015 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.009 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -4.534 |
MDCK | 0.0000214 |
BBB | 0.905 |
PPB | 0.834718 |
VDSS | 1.991 |
FU | 0.175181 |
CYP1A2-inh | 0.396 |
CYP1A2-sub | 0.17 |
CYP2c19-inh | 0.259 |
CYP2c19-sub | 0.84 |
CYP2c9-inh | 0.166 |
CYP2c9-sub | 0.343 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.473 |
CYP3a4-inh | 0.449 |
CYP3a4-sub | 0.302 |
CL | 9.541 |
T12 | 0.091 |
hERG | 0.009 |
Ames | 0.012 |
ROA | 0.021 |
SkinSen | 0.406 |
Carcinogencity | 0.729 |
EI | 0.688 |
Respiratory | 0.636 |
NR-Aromatase | 0.21 |
Antiviral | Yes |
Prediction | 0.783635 |